Focus Stocks
Baxter International Close to the 200 Day
Published on Tuesday, 07 February 2012 06:52 Written by TradersHuddle Wire
New York, February 7th (TradersHuddle.com) - Shares of Baxter International, Inc. (NYSE:BAX) traded at $57.11 close to its 200 day moving average currently set at $55.19. Baxter's price action is just above this key support level, and it will certainly raise traders attention, as a possible trading opportunity.
Baxter International Inc. (NYSE:BAX) develops, manufactures, and markets products and technologies related to hemophilia, immune disorders, infectious diseases, kidney disease, trauma and other chronic medical conditions. The healthcare products are used by hospitals, kidney dialysis centers, nursing homes, rehabilitation centers, doctors' offices, and research laboratories.
Latest price action range, defined by a peaks and troughs algorithm places calculated support at $47.55 and calculated resistance at $56.68. These levels will certainly be watched by traders, as they provide insight into the latest price dynamics defined by Baxter International stock.
Traders wanting to establish a position on Baxter International will be looking at the price action for evidence of buying near the 200 day moving average, and opening a position as close as possible to this important level. Also traders will be looking at the latest price action, via the stocks current range previously defined for insights of other key levels that might affect their upside or downside.
Related Articles
- The 200 Day Moving Average is Key for Baxter International
- Baxter’s Low Glucose PD Solutions Favorably Impacted Metabolic Measures Including Glycemic Control in Trials of Diabetics Undergoing Dialysis
- Baxter to Present at Goldman Sachs 33rd Annual Global Healthcare Conference
- Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A
- Baxter International Is Dipping Below Support
- Is Baxter International Close to Support?
- The 200 Day Moving Average is a Great Reference Point for Baxter International
- Is Baxter International Close to Support?
- Baxter Declares Quarterly Dividend
Related Partner Headlines
- 6 Low-Yield Dividend Captures - TheStreet.com
- Baxter Announces ADVATE Approval in China for the Treatment of Hemophilia A - Benzinga
- Baxter International Inc. (BAX): Today's Featured Health Services Loser - TheStreet.com
- 'Mad Money' Lightning Round: Devon's Worth More - TheStreet.com
- 7 Hot Stocks on Traders' Radars - TheStreet.com
- 'Mad Money' Lightning Round: Bullish on Baxter - TheStreet.com
- Baxter International Stock To Go Ex-dividend Tomorrow (BAX) - TheStreet.com
- UPDATE: Dougherty & Company Raises PT on Baxter International to $56 - Benzinga
- Baxter Receives Marketing Authorization in European Union for VEPACEL Pre-Pandemic Influenza Vaccine - Benzinga
- Baxter Initiates Phase III Adult Stem Cell Clinical Trial for Chronic Cardiac Condition - Benzinga
TradersHuddle Search
| Sponsored By: |
|
Stock Search: |
|
Site Search: Loading
|
Latest Partner Headlines
-
Something's Not Right in the Video-Game Space - TheStreet.com -
Stock Futures Rise on Eurobond Talk - TheStreet.com -
You Can Let Your Guard Down: Ask Noah - TheStreet.com -
NYSE Is Winning the IPO Listing War - TheStreet.com -
Apple Strengthens Its Supply Chain - TheStreet.com -
Toyota Is Back as May Sales Continue Auto Industry Recovery - TheStreet.com -
One Emotional Market - TheStreet.com -
Mixed Signals Emerge From Bakken Shale - TheStreet.com
Stock Market
Dow Jones
Company ID [INDEXDJX:.DJI] Last trade:12,529.75 Trade time:4:05PM EDT Value change:▲33.60 (0.27%)S&P 500
Company ID [INDEXSP:.INX] Last trade:1,320.68 Trade time:4:32PM EDT Value change:▲1.82 (0.14%)NASDAQ
Company ID [INDEXNASDAQ:.IXIC] Last trade:2,839.38 Trade time:5:16PM EDT Value change:▼10.74 (-0.38%)In The Wires
-
SunOpta Enters Into Agreement to Divest Its Canadian Based Natural Health Products Business -
PC Connection, Inc. (PCCC) To Present at The SeeThruEquity First Annual Small Cap Investor Conference on Tuesday, June 5, 2012 -
Aeroflex Announces Amendment to Credit Agreement -
Alliance Data to Participate at Upcoming Investor Conferences -
PCA3 Test Featured at American Urological Association Meeting -
MOCON Announces Quarterly Dividend -
Government of Rwanda Introduces Merck's ROTATEQ® (Rotavirus Vaccine, Live, Oral, Pentavalent) to Help Protect Children Against Rotavirus -
Continental Resources Names Kirk Kinnear as Vice President of Oil Marketing Logistics









